Abstract:The effects on locomotor response to cocaine challenge, acquisition of cocaine conditioned place preference and cocaine-induced dopamine (DA) release in nucleus accumbens and ventral tegmental area by the non-specific corticotropin-releasing factor (CRF) receptors antagonist alpha-helical CRF, the selective CRF receptor subtype 1 antagonist CP-154,526 and the selective CRF receptor subtype 2 antagonist anti-sauvagine-30 (AS-30) were investigated in rats. Both alpha-helical CRF (10 mug, i.c.v.) and CP-154,526 (3 mug, i.c.v.) decreased the cocaine-induced distance travelled, whereas AS-30 (3 mug, i.c.v.) did not show such an effect. The CRF receptor antagonists also have significant effects on stereotype counts induced by cocaine injection, in which the alpha-helical CRF or CP-154,526 but not AS-30 did significantly reduce the stereotype counts. alpha-Helical CRF (10 mug) prior to each injection of cocaine blocked cocaine conditioned place preference with no significant difference observed in the time spent in the drug-paired side between post- and pre-training and both 1 and 3 mug CP-154,526 also had significant inhibitory effects on cocaine-induced place preference. However, pre-treatment with an i.c.v. infusion of AS-30 (1 or 3 mug) prior to each injection of cocaine did not affect the acquisition of conditioned place preference. The alpha-helical CRF and CP-154,526 reduced extracellular DA levels of nucleus accumbens and ventral tegmental area in response to the injection of cocaine. However, both alpha-helical CRF and CP-154,526 did not modify extracellular DA levels under basal conditions. In contrast, the i.c.v. infusion of AS-30 had no effects on either the basal DA or the cocaine-induced increase in DA release in nucleus accumbens and ventral tegmental area. These findings demonstrate that activation of the CRF receptor is involved in behavioral and neurochemical effects of cocaine challenge and cocaine reward and that the role of CRF receptor subtypes 1 and 2 in cocaine-induced locomotion, reward and DA release is not identical. The CRF receptor subtype 1 is largely responsible for the action of the CRF system on cocaine locomotion and reward. These results suggest that the CRF receptor antagonist, particularly the CRF receptor subtype 1 antagonist, might be of some value in the treatment of cocaine addiction and cocaine-related behavioral disorders.

Time-dependent alterations in corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration to rats

Chronic Cocaine-Regulated Epigenomic Changes in Mouse Nucleus Accumbens.

CREB Binding at the Zfp189 Promoter Within Medium Spiny Neuron Subtypes Differentially Regulates Behavioral and Physiological Adaptations over the Course of Cocaine Use.

Cocaine Dynamically Regulates Heterochromatin And Repetitive Element Unsilencing In Nucleus Accumbens

Cocaine-Induced Chromatin Modifications Associate with Increased Expression and Three-Dimensional Looping of Auts2.

Cocaine Exposure Modulates Perineuronal Nets and Synaptic Excitability of Fast-Spiking Interneurons in the Medial Prefrontal Cortex

Prominent Activation of Brainstem and Pallidal Afferents of the Ventral Tegmental Area by Cocaine

Dopamine-Dependent Responses To Cocaine Depend On Corticotropin-Releasing Factor Receptor Subtypes

Heterogeneous Neuronal Activity in the Lateral Habenula after Short‐ and Long‐term Cocaine Self‐administration in Rats

CRFR1 in the ventromedial caudate putamen modulates acute stress-enhanced expression of cocaine locomotor sensitization.

Cocaine Modulation of Frontostriatal Expression of Zif268, D2, and 5-Ht2c Receptors in High and Low Impulsive Rats

Cellular and molecular responses to acute cocaine treatment in neuronal-like N2a cells: potential mechanism for its resistance in cell death

Cocaine induces locomotor sensitization through a dopamine-dependent VTA-mPFC-FrA cortico-cortical pathway in male mice

Effects of Cocaine Place Conditioning, Chronic Escalating-Dose “binge” Pattern Cocaine Administration and Acute Withdrawal on Orexin/hypocretin and Preprodynorphin Gene Expressions in Lateral Hypothalamus of Fischer and Sprague–Dawley Rats

Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin

The Effect of Cocaine Sensitization on Mouse Immunoreactivity

Region-specific effects of developmental exposure to cocaine on fibroblast growth factor-2 expression in the rat brain

Repeated in Vivo Exposure of Cocaine Induces Long-Lasting Synaptic Plasticity in Hypocretin/orexin-Producing Neurons in the Lateral Hypothalamus in Mice.

Single cocaine exposure attenuates the intrinsic excitability of CRH neurons in the ventral BNST via Sigma-1 receptors

A Neuronal Activation Correlate in Striatum and Prefrontal Cortex of Prolonged Cocaine Intake

Acute, but not repeated, cocaine exposure alters allopregnanolone levels in the midbrain of male and female rats